Sleeping Pills Could Halt Alzheimer's Progression, Study Suggests

A small study has shown that suvorexant, a sleep medication commonly prescribed to treat insomnia, reduced levels of the Alzheimer’s-associated amyloid beta protein and hyperphosphorylated tau protein in the brain. The study suggests that sleep medications could slow or stop the progression of Alzheimer’s disease, but more research is needed to confirm the viability of such an approach.